Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children
- PMID: 18760193
- DOI: 10.1016/j.arcmed.2008.05.008
Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children
Abstract
Background: Brain stem tumors (BST) constitute 20% of all intracranial tumors. Survival for these patients has been very poor worldwide. Four different treatment schemes have been evaluated at our institution, with only a discrete increment in survival when treated with carboplatin-vincristine and fluvastatin (CVF). Low-dose, continuous antiangiogenic treatment has been recently introduced in the treatment of cancer. Our objective was to determine tumor response to metronomic chemotherapy combined with an antiangiogenic drug and fluvastatin and to calculate the survival of pediatric patients with brain stem tumors.
Methods: This was a phase II study. A magnetic resonance (MRI) study was made at inclusion and after the fourth course. Routine laboratory analyses were performed prior to each treatment scheme. Patients received four courses of chemotherapy every 28 days consisting of thalidomide alternating with fluvastatin every 14 days and combined with carboplatin and vincristine every 14 days followed by radiotherapy (56 cGy) and four more courses of the same chemotherapy. Toxicity was evaluated according to Miller criteria.
Results: Nine recently diagnosed BST patients were included. Five patients had low-grade astrocytomas, three patients had glioblastoma multiforme, and one patient presented high-grade astrocytoma. There was a significant reduction in tumor volume and a significant increase in survival at 24 months. Two patients died. Toxicity included carboplatin allergy in one patient, grades 1 and 3 neutropenia in two patients, and grade 4 thrombocytopenia in two patients.
Conclusions: Metronomic treatment with carboplatin and vincristine associated with fluvastatin and thalidomide significantly increased survival of pediatric brain stem tumor patients. Tumor volume showed a significant reduction. Quality of life was also increased. Sample size must be increased in order to make final conclusions.
Similar articles
-
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.Cancer. 2004 Feb 15;100(4):807-13. doi: 10.1002/cncr.20042. Cancer. 2004. PMID: 14770438 Clinical Trial.
-
Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.Cancer. 2005 Dec 15;104(12):2862-71. doi: 10.1002/cncr.21593. Cancer. 2005. PMID: 16315242 Clinical Trial.
-
A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.Cancer. 2005 Nov 1;104(9):1968-74. doi: 10.1002/cncr.21403. Cancer. 2005. PMID: 16177987 Clinical Trial.
-
Intramedullary spinal cord astrocytomas in children.Pediatr Blood Cancer. 2004 Nov;43(6):629-32. doi: 10.1002/pbc.20082. Pediatr Blood Cancer. 2004. PMID: 15390309 Review.
-
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.Semin Oncol. 2003 Apr;30(2):265-9. doi: 10.1053/sonc.2003.50079. Semin Oncol. 2003. PMID: 12720150 Review.
Cited by
-
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma.Cancers (Basel). 2021 Nov 22;13(22):5869. doi: 10.3390/cancers13225869. Cancers (Basel). 2021. PMID: 34831022 Free PMC article.
-
Daily high doses of atorvastatin alter neuronal morphology in a juvenile songbird model.PLoS One. 2025 Apr 28;20(4):e0314690. doi: 10.1371/journal.pone.0314690. eCollection 2025. PLoS One. 2025. PMID: 40294005 Free PMC article.
-
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.Semin Cancer Biol. 2021 Jan;68:105-122. doi: 10.1016/j.semcancer.2019.12.013. Epub 2019 Dec 26. Semin Cancer Biol. 2021. PMID: 31883910 Free PMC article. Review.
-
Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.Transl Oncol. 2011 Aug;4(4):203-11. doi: 10.1593/tlo.11124. Epub 2011 Aug 1. Transl Oncol. 2011. PMID: 21804915 Free PMC article.
-
The role of statins in neurosurgery.Neurosurg Rev. 2010 Jul;33(3):259-70; discussion 270. doi: 10.1007/s10143-010-0259-4. Epub 2010 Apr 29. Neurosurg Rev. 2010. PMID: 20429022
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources